Document is current
Any future updates will be listed below
-
Authors
Sideris, Michail
Maniati, Eleni
Kader, Tanjina
Santagata, Sandro
Drapkin, Ronny
Balkwill, Frances
Manchanda, Ranjit https://orcid.org/0000-0003-3381-5057
-
Funding
Funding for this research was provided by:
UKRI Frontier Research grant (EP/X028704/1)
City of London CRUK Core Award (CTRQQR-2021\100004)
- License Information
-
More Information
Article History
Received: 18 March 2026
Accepted: 19 August 2026
First Online: 26 August 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Consent for publication: Not applicable.
Competing interests: RM reports research funding grants from GSK, Yorkshire Cancer Research, Rosetrees Trust, Barts Charity, Cancer Research UK outside the submitted work, and honoraria for advisory board membership from Astrazeneca/MSD/GSK/EGL. FB declares research funding from AstraZeneca and has received an honorarium from Glaxo Smith Kline. RD serves on the scientific advisory board of Repare Therapeutics and reports speaker fees from GSK. TK, SS, MS and EM declare no conflict of interest.
